Rapid penetration in developed countries with wide prevalence of valvular heart diseases driving TPVR market

According to a research report titled ‘Global Transcatheter Pulmonary Valve Replacement (TPVR) Market – Analysis By Application Type, By End User, By Region, By Country (2020 Edition): Market Insights, Competition and Forecast (2020-2025)’ published by Azoth Analytics in June 2020, the Global Transcatheter Pulmonary Valve Replacement Market was valued at USD 287.6 million in the year 2019. The growth in the market for Transcatheter Pulmonary Valve Replacement is chiefly accredited to rapid penetration in developed countries with wide prevalence of valvular heart diseases and escalating number of pipeline products with rapid adoption of latest technology and increasing awareness about the benefits of TPVR. These factors will push the Transcatheter Pulmonary Valve Replacement market growth in the coming years.

The Azoth Analytics research report titled Global Transcatheter Pulmonary Valve Replacement Market (2020 Edition) has analysed and segmented the Transcatheter Pulmonary Valve Replacement Market by Value (USD million). The report covers the Transcatheter Pulmonary Valve Replacement Market By Application Type (Pulmonary Stenosis, Pulmonary Regurgitation, Others), By End User (Hospitals, Ambulatory Surgical Centers, Others). The Global Transcatheter Pulmonary Valve Replacement Market has been analysed By Region (North America, Europe, and Asia Pacific) and By Country (United States, Germany, China) for the forecast period of 2020-2025.

Global Transcatheter Pulmonary Valve Replacement market will be majorly driven by increasing penetration with major developments in TPVR technology which allows easier implantation and better outcome coupled with rapidly mounting population suffering from cardiovascular diseases with increase in demand for less invasive procedures, including companies investing hefty amounts in expanding their product portfolio and geographical presence. All these factors are likely to drive a remarkable growth in the market for Transcatheter Pulmonary Valve Replacement during the coming years.  

Moreover, Pulmonary Regurgitation will be witnessing notable growth in the application type segment and is anticipated to account for the largest market share owing to growing adoption of less invasive procedures and preferring TPVR over SAVR procedure supported by key players providing these procedures to the patients at low cost and are constantly engaged in offering a wide range of products in order to provide increased life expectancy. This will be infusing notable growth in the market for Transcatheter Pulmonary Valve Replacement in future.

Furthermore, among the regions, Europe is anticipated to attain the highest market share followed by North America and APAC owing to escalating growth in demand for less invasive procedures which will prove to be more effective for the patients with heart diseases clubbed with presence of positive economic growth and increasing incidence of Pulmonary Stenosis and Pulmonary Regurgitation backed with demand for effective and less invasive products in countries including Italy, France among others.